APPH logo

Apontis Pharma AG Stock Price

XTRA:APPH Community·€91.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

APPH Share Price Performance

€11.00
0.95 (9.45%)
€11.00
0.95 (9.45%)
Price €11.00

APPH Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

1 Risk
3 Rewards

Apontis Pharma AG Key Details

€51.8m

Revenue

€21.7m

Cost of Revenue

€30.1m

Gross Profit

€29.5m

Other Expenses

€654.5k

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.079
58.16%
1.26%
0%
View Full Analysis

About APPH

Founded
1946
Employees
137
CEO
Sascha Glanemann
WebsiteView website
apontis-pharma.de

Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, dylipidemia, secondary prophylaxis, and asthma, as well as respiratory diseases and diabetes. The company was founded in 1946 and is based in Monheim am Rhein, Germany. Apontis Pharma AG operates as a subsidiary of Zentiva AG.

Recent APPH News & Updates

Recent updates

No updates